Geovax Labs (GOVX) Stock Price, Quote & News

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology

Sector: Healthcare

Phone: (678) 384-7220

Fax: (678) 384-7281

Website: www.geovax.com

Address:

1900 Lake Park Drive, Suite 380, Smyrna, United States

Waffels Jul. 15 at 11:26 PM

$GOVX not to brag but I am in fact gay. Everyone knows we are good at trading stocks

1 · Reply

juvie22 Jul. 15 at 8:07 PM

$GOVX

0 · Reply

geniuscali Jul. 15 at 7:26 PM

$GOVX join the party and short this turd.

0 · Reply

lealbinagor98 Jul. 15 at 5:24 PM

$CYCC let's up $NVAX $GOVX $GNLN 🔥⏰️🚀😎👋

1 · Reply

geniuscali Jul. 15 at 3:19 PM

$GOVX should hear about Reverse Split soon

1 · Reply

TraderUKBoyy Jul. 15 at 2:09 PM

$GOVX Lets hope they give some meaningful updates tomorrow or it’s gonna be same Blah Blah Blah 😕 No major effect of this new yet on the share price !! Let’s see what rest of the week brings in.. It’s good as long as overpaid mgmt don’t announce next offering or RS !! 🤞🤞🤞

1 · Reply

Martian_Paradisee Jul. 14 at 11:56 PM

$GOVX Stay bullish.

0 · Reply

ZacksResearch Jul. 14 at 1:37 PM

$GOVX trading under $1 — value trap or hidden gem? 🧬📉 It’s down 72.6% year to date and trading at a 12-month trailing P/B of 1.36 — way below the industry average of 3.11, but right in line with its 5-year mean of 1.33. Is this pricing in future pain — or overlooking upside potential? See what Wall Street analysts recommend 👉 https://www.zacks.com/stock/research/GOVX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-1479&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_1479

0 · Reply

lealbinagor98 Jul. 14 at 1:02 PM

$DARE nice pre market $NVAX $GNLN $GOVX $CHRS ⏰️🚀🔥👋😎🤑

0 · Reply

MrMaxxxx Jul. 14 at 12:31 PM

$GOVX Me like.

0 · Reply

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 3 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Dec 9, 2024, 9:00 AM EST - 7 months ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Nov 26, 2024, 9:00 AM EST - 8 months ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 12, 2024, 11:33 PM EST - 8 months ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:00 PM EST - 8 months ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 5, 2024, 9:00 AM EST - 9 months ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Oct 2, 2024, 9:00 AM EDT - 10 months ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 3, 2024, 9:00 AM EDT - 11 months ago

GeoVax to Participate in Upcoming Investor Conferences in September

Aug 28, 2024, 8:59 PM EDT - 11 months ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 20, 2024, 8:09 AM EDT - 11 months ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 7:45 AM EDT - 11 months ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:00 AM EDT - 11 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

Aug 19, 2024, 7:30 AM EDT - 11 months ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 15, 2024, 9:00 AM EDT - 11 months ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 8:36 AM EDT - 11 months ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

Aug 10, 2024, 6:15 AM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 9:00 AM EDT - 1 year ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 6, 2024, 4:00 PM EDT - 1 year ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 31, 2024, 10:15 AM EDT - 1 year ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

Apr 4, 2024, 12:30 PM EDT - 1 year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Mar 28, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 12, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the 36th Annual Roth Conference

Mar 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 1, 2024, 2:34 AM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 22, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 19, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 13, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Jan 29, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 8, 2024, 9:00 AM EST - 1 year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 4, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 3, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

Dec 27, 2023, 9:00 AM EST - 1 year ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 19, 2023, 9:00 AM EST - 1 year ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Nov 30, 2023, 4:30 PM EST - 1 year ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 29, 2023, 9:00 AM EST - 1 year ago

GeoVax to Participate in Upcoming December Investor Events

Nov 28, 2023, 9:00 AM EST - 1 year ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 14, 2023, 9:00 AM EST - 1 year ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 8, 2023, 9:26 PM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:00 PM EST - 1 year ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Oct 30, 2023, 9:00 AM EDT - 1 year ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 25, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 24, 2023, 9:00 AM EDT - 1 year ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 9, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Sep 27, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming October Investor and Industry Events

Sep 20, 2023, 9:00 AM EDT - 1 year ago

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

Waffels Jul. 15 at 11:26 PM

$GOVX not to brag but I am in fact gay. Everyone knows we are good at trading stocks

1 · Reply

juvie22 Jul. 15 at 8:07 PM

$GOVX

0 · Reply

geniuscali Jul. 15 at 7:26 PM

$GOVX join the party and short this turd.

0 · Reply

lealbinagor98 Jul. 15 at 5:24 PM

$CYCC let's up $NVAX $GOVX $GNLN 🔥⏰️🚀😎👋

1 · Reply

geniuscali Jul. 15 at 3:19 PM

$GOVX should hear about Reverse Split soon

1 · Reply

TraderUKBoyy Jul. 15 at 2:09 PM

1 · Reply

Martian_Paradisee Jul. 14 at 11:56 PM

$GOVX Stay bullish.

0 · Reply

ZacksResearch Jul. 14 at 1:37 PM

0 · Reply

lealbinagor98 Jul. 14 at 1:02 PM

$DARE nice pre market $NVAX $GNLN $GOVX $CHRS ⏰️🚀🔥👋😎🤑

0 · Reply

MrMaxxxx Jul. 14 at 12:31 PM

$GOVX Me like.

0 · Reply

ChasingtheLambo Jul. 14 at 12:08 PM

$GOVX 👍

0 · Reply

Ueberschlaefer Jul. 14 at 10:06 AM

$GOVX $SONN hit $30 in PM on announcement of its crypto treasury strategy. GOVX is chasing covid jabs, facing extinction. other biotechs are figuring out ways to generate recurring revenue to fund themselves since the biotech scam is winding down. GOVX is going to dilute and beg in the streets for cash from private speculative funds.

0 · Reply

DavidScott Jul. 14 at 3:03 AM

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $HOLO $AMC $MLGO $GOVX $GME

0 · Reply

WallStreetBuyDip Jul. 12 at 11:42 AM

Traded $GOVX before along with other small/mid caps. I only buy when H% is low. It takes patience but the results always speak for themselves. I make this to see if the strategy is successful or not.

0 · Reply